CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) [Phase 3]

Phase 3, vehicle-controlled study of IDP-123 Lotion for acne vulgaris has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bausch Health Americas, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2021-04-01